Skip to content

144Accepted Jan 8, 9:21 AM ET

Abivax S.A. 144

Sofinnova Crossover I

Accepted (ET)

9:21 AM

Jan 8, 2026

Filed

Jan 8, 2026

Documents

1

Size

5.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.